Goertsen, David
Flytzanis, Nicholas C.
Goeden, Nick
Chuapoco, Miguel R. http://orcid.org/0000-0001-5397-996X
Cummins, Alexander
Chen, Yijing
Fan, Yingying
Zhang, Qiangge
Sharma, Jitendra
Duan, Yangyang http://orcid.org/0000-0002-0823-6574
Wang, Liping http://orcid.org/0000-0001-6893-3809
Feng, Guoping http://orcid.org/0000-0002-8021-277X
Chen, Yu
Ip, Nancy Y. http://orcid.org/0000-0002-2763-8907
Pickel, James http://orcid.org/0000-0002-3617-3072
Gradinaru, Viviana http://orcid.org/0000-0001-5868-348X
Article History
Received: 16 June 2020
Accepted: 22 October 2021
First Online: 9 December 2021
Competing interests
: The California Institute of Technology has filed and licensed patent applications for the work described in this manuscript, with N.C.F., N.G. and V.G. listed as inventors (US Patent application no. 16/582,635, 2020). V.G. is a co-founder and board member and N.C.F. and N.G. are co-founders and employees of Capsida Biotherapeutics, a fully integrated AAV engineering and gene therapy company. Capsida Biotherapeutics did not provide funding and had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.